The classic website will no longer be available as of June 25, 2024. Please use the modernized ClinicalTrials.gov.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Fibersol-2 Clinical Trials Related to Appetite

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01305291
Recruitment Status : Completed
First Posted : February 28, 2011
Last Update Posted : February 28, 2011
Sponsor:
Collaborator:
Archer Daniels Midland Co.
Information provided by:
Iowa State University

Brief Summary:
Emerging research suggests fiber, particularly digestion-resistant maltodextrins such as Fibersol-2, may impact satiety, by decreasing hunger, prolonging satiation, and/or increasing satiety signals from the gut. This research aims to determine whether or not Fibersol-2 may impact satiety, by decreasing hunger, prolonging satiation, and/or increasing satiety signals from the gut.

Condition or disease Intervention/treatment Phase
Lack of Satiety Other: placebo Dietary Supplement: digestion-resistant maltodextrin Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 20 participants
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Double (Participant, Investigator)
Primary Purpose: Basic Science
Official Title: Fibersol-2 Clinical Trials Related to Appetite
Study Start Date : November 2008
Actual Primary Completion Date : July 2009
Actual Study Completion Date : November 2009

Arm Intervention/treatment
Placebo Comparator: tea only without fibersol-2
  • On the day before the test, subjects need to consume their evening meal before 9 pm, and fast until the start of the test the next day.
  • The evening meal will be a standardized meal for all subjects (11).
  • They are allowed to consume water up until 1 hr before the test.
  • Before the start of the test a cannula will be inserted into the ante-cubital arm vein for use of repeated blood sampling (11).
  • The beverage will be consumed at 10 am.
  • Blood samples will be taken at specified time points prior to after the treatments.
Other: placebo
Active Comparator: tea only with fibersol-2 (10 g)
  • On the day before the test, subjects need to consume their evening meal before 9 pm, and fast until the start of the test the next day.
  • The evening meal will be a standardized meal for all subjects.
  • They are allowed to consume water up until 1 hr before the test.
  • Before the start of the test a cannula will be inserted into the ante-cubital arm vein for use of repeated blood sampling (11).
  • The beverage will be consumed at 10 am.
  • Blood samples will be taken at specified time points prior to and after the treatments.
  • Ingredient only test will be done without the meal to determine independent effects of Fibersol-2.
Dietary Supplement: digestion-resistant maltodextrin
Other Name: Fibersol-2

Placebo Comparator: tea without fibersol-2 and meal
  • On the day before the test, subjects need to consume their evening meal before 9 pm, and fast until the start of the test the next day.
  • The evening meal will be a standardized meal for all subjects.
  • They are allowed to consume water up until 1 hr before the test.
  • Before the start of the test a cannula will be inserted into the ante-cubital arm vein for use of repeated blood sampling.
  • The test meal and beverage will be consumed at 10 am.
  • The meal will consist of pasta meal (main pasta dish = Carb 64.5%, Fat 17.7%, Protein 17.8%; total kcal 739).
  • Tea containing test materials will accompany the meal.
  • Blood samples will be taken at specified time points prior to and after the treatments.
Other: placebo
Experimental: tea with 5 g fibersol-2 and meal
  • On the day before the test, subjects need to consume their evening meal before 9 pm, and fast until the start of the test the next day.
  • The evening meal will be a standardized meal for all subjects.
  • They are allowed to consume water up until 1 hr before the test.
  • Before the start of the test a cannula will be inserted into the ante-cubital arm vein for use of repeated blood sampling.
  • The test meal and beverage will be consumed at 10 am.
  • The meal will consist of pasta meal (main pasta dish = Carb 64.5%, Fat 17.7%, Protein 17.8%; total kcal 739).
  • Tea containing test materials will accompany the meal.
  • Blood samples will be taken at specified time points prior to and after the treatments.
Dietary Supplement: digestion-resistant maltodextrin
Other Name: Fibersol-2

Experimental: tea with 10 g fibersol-2 and meal
  • On the day before the test, subjects need to consume their evening meal before 9 pm, and fast until the start of the test the next day.
  • The evening meal will be a standardized meal for all subjects.
  • They are allowed to consume water up until 1 hr before the test.
  • Before the start of the test a cannula will be inserted into the ante-cubital arm vein for use of repeated blood sampling.
  • The test meal and beverage will be consumed at 10 am.
  • The meal will consist of pasta meal (main pasta dish = Carb 64.5%, Fat 17.7%, Protein 17.8%; total kcal 739).
  • Tea containing test materials will accompany the meal.
  • Blood samples will be taken at specified time points prior to and after the treatments.
Dietary Supplement: digestion-resistant maltodextrin
Other Name: Fibersol-2




Primary Outcome Measures :
  1. Visual analog scale questionnaire subjective satiety responses [ Time Frame: 4 hours ]
    Hunger survey (30 minutes before meal and every half hour for 4 hours postprandial) (analogue scores)

  2. serum cholecystokinin (CCK) [ Time Frame: 4 hours ]
    0, 30, 60, 120, 180, and 240 min post-meal

  3. serum peptide YY (PYY) [ Time Frame: 4 hours ]
    0, 30, 60, 120, 180, and 240 min post-meal

  4. serum glucagon-like peptide-1 (GLP-1) [ Time Frame: 4 hours ]
    0, 30, 60, 120, 180, and 240 min post-meal

  5. serum ghrelin [ Time Frame: 4 hours ]
    0, 30, 60, 120, 180, and 240 min post-meal

  6. serum gastric inhibitory peptide (GIP) [ Time Frame: 4 hours ]
    0, 30, 60, 120, 180, and 240 min post-meal


Secondary Outcome Measures :
  1. serum total cholesterol [ Time Frame: 4 hours ]
    0, 30, 60, 120, 180, 240 min

  2. serum LDL-cholesterol [ Time Frame: 4 hours ]
    0, 30, 60, 120, 180, 240 min

  3. serum HDL-cholesterol [ Time Frame: 4 hours ]
    0, 30, 60, 120, 180, 240 min

  4. serum triglycerides [ Time Frame: 4 hours ]
    0, 30, 60, 120, 180, 240 min

  5. serum free fatty acids [ Time Frame: 4 hours ]
    0, 30, 60, 120, 180, 240 min

  6. serum glucose [ Time Frame: 2 hours ]
    0, 30, 60, 90, 120 min

  7. serum insulin [ Time Frame: 2 hours ]
    0, 30, 60, 90, 120 min

  8. gastrointestinal symptoms questionnaire [ Time Frame: 24 h ]
    subjects recorded incidents and severity of gastrointestinal symptoms post treatment over 24 h



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 62 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

i. No known food allergies

ii. Normal healthy individuals

iii. No food intake abnormalities or abnormal feeding behaviors

iv. Average American BMI (21-28)


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01305291


Locations
Layout table for location information
United States, Iowa
Nutrition and Wellness Research Center
Ames, Iowa, United States, 50011
Sponsors and Collaborators
Iowa State University
Archer Daniels Midland Co.
Investigators
Layout table for investigator information
Principal Investigator: Suzanne Hendrich, PhD Iowa State University
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Suzanne Hendrich, Iowa State University
ClinicalTrials.gov Identifier: NCT01305291    
Other Study ID Numbers: ADM FB2-1 Hendrich
08-291 ( Other Identifier: ISU IRB )
First Posted: February 28, 2011    Key Record Dates
Last Update Posted: February 28, 2011
Last Verified: February 2011
Keywords provided by Iowa State University:
dietary fiber
satiety response
hunger
CCK
PYY
ghrelin
GIP
GLP-1